On March 10, 2023, Virax Biolabs Group Limited closed the transaction. The company has received funding pursuant to Regulation D from one investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.28 USD | +13.27% | +14.29% | -12.33% |
11/06 | Virax Biolabs Group Limited Announces Executive Changes | CI |
06/06 | Top Premarket Gainers | MT |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.33% | 2.67M | |
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |
- Stock Market
- Equities
- VRAX Stock
- News Virax Biolabs Group Limited
- Virax Biolabs Group Limited announced that it has received $4.000001 million in funding